Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan) data from the Phase III PSMAddition…
In a world where delays cost millions, this AI copilot shows teams what's changing, what to do, and what happens…